Vowst capsule 12S
Ended Awarded
- Contract number
- SPE2DB25FX2FZ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,173
Award facts
- Contract value 100% obligated
- $13,172.58 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $13,172.58 to DMS Pharmaceutical Group Inc. for the supply of Vowst Capsule 12S on September 26, 2025, with an ultimate completion date of October 20, 2025. This firm fixed-price delivery order was issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA under the SPE2DB program, a $500 million vehicle valid through November 2026. The award carries no set-aside designation, and the place of performance is Park Ridge, Illinois, where the woman-owned small business is headquartered.
DMS Pharmaceutical Group Inc., a registered pharmaceutical wholesaler and small business entity, serves as a critical supplier within the federal pharmaceutical supply chain, providing comprehensive medical supplies and medications to Department of Defense healthcare facilities nationwide. The company's substantial IDC with DLA enables it to fulfill delivery orders for branded and generic prescription drugs, biologics, and medical consumables supporting military health operations globally. This particular delivery order for Vowst Capsule 12S represents a continuation of DMS Pharmaceutical Group's consistent engagement in federal pharmaceutical procurement and supports DLA's mission to supply essential medications and medical products to defense healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FX2FZ?
SPE2DB25FX2FZ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 26, 2025.
How much is contract SPE2DB25FX2FZ worth?
The government has obligated $13,173 on SPE2DB25FX2FZ.
Is contract SPE2DB25FX2FZ an order under another contract?
Yes. SPE2DB25FX2FZ is a delivery order under SPE2DB22D9353, an indefinite delivery contract.
Was contract SPE2DB25FX2FZ competed?
The extent of competition for SPE2DB25FX2FZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award